ARCHIVES

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

DCT Issues New Program Announcement On Clinical Research

December 5, 1980

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Weight Gain After Diagnosis Increases Risk Of Death

December 28, 2007

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995

NCI To Establish New Offices for Special Populations, Survivorship, Klausner Tells House appropirations Subcommittee

May 3, 1996